Anxiety in Athletes and Gym-Goers: Prevention, Diagnosis and When to Get Help
Racing heart, tight chest, restless nights and a sense that something is about to go wrong: anxiety can feel intensely physical, which is why active people often look for a physical explanation first. Sometimes there is one — too much caffeine, a stimulant-heavy pre-workout or a hormonal substance. Sometimes there is not. Our editorial team explains how to recognise anxiety, what in the sporting environment can provoke it, and when to seek help.
What anxiety is and how common it is in sport
Anxiety is a normal response to threat. Before a competition, an exam or a heavy max attempt, a degree of nervousness sharpens focus. It becomes a problem when it is out of proportion to the situation, persists for weeks, or starts to limit daily life.
Clinicians recognise several anxiety disorders, including generalised anxiety disorder (GAD), panic disorder, social anxiety and health anxiety. Symptoms span the mind and the body: constant worry, irritability, poor concentration, palpitations, sweating, trembling, breathlessness, dizziness and disturbed sleep.
Elite sport does not protect against mental health problems. A meta-analysis by Gouttebarge and colleagues found that symptoms of anxiety and depression were reported by a substantial proportion of current elite athletes, at rates broadly comparable with the general population. The IOC consensus statement on mental health (2019) highlights performance pressure, injury, career transitions and body image as specific stressors.
Recreational gym-goers face their own pressures, including social media comparison and preoccupation with physique. Muscle dysmorphia, an intense concern about not being muscular enough, often coexists with anxiety and can be a pathway towards use of performance-enhancing drugs.
Substances and supplements that can trigger it
Many products used around training act on the nervous system. When symptoms begin soon after starting a new product or increasing a dose, the timing is a useful clue.
| Substance | How it may contribute | Comment |
|---|---|---|
| Caffeine and pre-workouts | Stimulates the sympathetic nervous system | Large doses can provoke panic-like symptoms |
| Other stimulants (e.g. synephrine, DMAA-type compounds) | Raise heart rate and blood pressure | DMAA-type ingredients are banned in sport and linked to serious harm |
| Thyroid hormones, clenbuterol | Increase metabolic rate, cause tremor and palpitations | Prescription or unlicensed drugs with cardiac risks |
| Anabolic steroids | Affect mood, irritability and sleep | Anxiety and depression may follow withdrawal |
| Alcohol and cannabis | Rebound anxiety after use | Common in post-competition settings |
Lara's review of caffeine and mental health notes that high caffeine intake can induce anxiety, especially in people with a pre-existing anxiety or panic disorder. Some pre-workout servings contain as much caffeine as several cups of coffee, and taking two scoops or combining them with energy drinks multiplies this.
The Endocrine Society statement by Pope and colleagues describes mood changes associated with anabolic steroids, including irritability and aggression during use and depressive and anxious symptoms after stopping. These effects vary widely between individuals but are a recognised harm.
How anxiety is assessed
There is no single test for anxiety. A GP will take a history covering symptoms, their duration, triggers, sleep, alcohol and substance use, and how they affect daily life. Honesty about supplements and any performance-enhancing drugs is essential.
Questionnaires help to quantify symptoms. The GAD-7, developed by Spitzer and colleagues, asks about seven common symptoms over the previous two weeks and is widely used in UK primary care and NHS Talking Therapies services.
Because anxiety symptoms overlap with physical conditions, a doctor may check pulse, blood pressure and sometimes blood tests. An overactive thyroid, heart rhythm disorders, low blood sugar, anaemia and substance effects can all mimic or worsen anxiety.
NICE guideline CG113 describes a stepped-care approach: from information and guided self-help, through psychological therapies such as cognitive behavioural therapy (CBT), to medication where appropriate. Most people can access talking therapies by self-referral through the NHS.
Prevention and self-help that work
Exercise is one of the best-supported self-help measures. A meta-analysis by Stubbs and colleagues found that exercise reduced anxiety symptoms in people with anxiety and stress-related disorders. The key is regular, moderate training, not punishing sessions driven by guilt or body-image worries.
- Audit your stimulant intake and reduce it gradually rather than stopping abruptly.
- Avoid caffeine and pre-workouts in the afternoon and evening.
- Protect sleep with a consistent schedule.
- Eat regularly; long fasts combined with stimulants can intensify symptoms.
- Learn a simple breathing technique, such as slow exhalation, for acute surges.
- Limit social media accounts that leave you feeling inadequate about your body.
For athletes, sport psychologists can help with performance anxiety using techniques such as pre-performance routines, imagery and reframing of arousal. These skills are teachable and evidence-based.
Avoiding performance-enhancing drugs altogether is the most effective prevention of drug-related anxiety. For those who already use them, specialist harm-reduction services offer confidential support and health checks without judgement.
When to see a doctor
See your GP or self-refer to NHS Talking Therapies if anxiety lasts more than a few weeks, interferes with work, study, training or relationships, or if you find yourself avoiding situations because of it.
Seek urgent medical help for chest pain, fainting, a very fast or irregular heartbeat, or severe breathlessness — especially after taking stimulants or other substances. These symptoms need to be assessed to exclude heart problems before being attributed to anxiety.
If you have thoughts of harming yourself, contact NHS 111 (option 2 for mental health in many areas), call Samaritans on 116 123, or go to A&E. In immediate danger, call 999.
If you stop using anabolic steroids or other hormonal substances and experience low mood or anxiety, tell your GP. Withdrawal-related symptoms are recognised and treatable.
Conclusions of the editorial team
Anxiety is common among athletes and gym-goers and often presents with physical symptoms. Stimulants, fat burners and hormonal drugs can trigger or worsen it.
Regular moderate exercise, sensible caffeine habits, good sleep and psychological skills help prevent and manage symptoms. Effective treatments, including CBT, are available through the NHS.
Persistent or severe anxiety, and any chest pain or palpitations after taking substances, warrant medical assessment.
Related topics worth exploring include caffeine tolerance and safety, muscle dysmorphia, and sleep for recovery.
References
- National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management (CG113). London: NICE; 2011.
- Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097.
- Reardon CL, Hainline B, Aron CM, et al. Mental health in elite athletes: International Olympic Committee consensus statement (2019). Br J Sports Med. 2019;53(11):667–699.
- Gouttebarge V, Castaldelli-Maia JM, Gorczynski P, et al. Occurrence of mental health symptoms and disorders in current and former elite athletes: a systematic review and meta-analysis. Br J Sports Med. 2019;53(11):700–706.
- Stubbs B, Vancampfort D, Rosenbaum S, et al. An examination of the anxiolytic effects of exercise for people with anxiety and stress-related disorders: a meta-analysis. Psychiatry Res. 2017;249:102–108.
- Lara DR. Caffeine, mental health, and psychiatric disorders. J Alzheimers Dis. 2010;20 Suppl 1:S239–S248.
- Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.
